Doxycycline‐Induced Expression of Transgenic Human Tumor Necrosis Factor α in Adult Mice Results in Psoriasis‐like Arthritis
Open Access
- 5 June 2013
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 65 (9) , 2290-2300
Abstract
Objective: To generate doxycycline‐inducible human tumor necrosis factor α (TNFα)–transgenic mice to overcome a major disadvantage of existing transgenic mice with constitutive expression of TNFα, which is the limitation in crossing them with various knockout or transgenic mice.Methods: A transgenic mouse line that expresses the human TNFα cytokine exclusively after doxycycline administration was generated and analyzed for the onset of diseases.Results: Doxycycline‐inducible human TNFα–transgenic mice developed an inflammatory arthritis– and psoriasis‐like phenotype, with fore and hind paws being prominently affected. The formation of “sausage digits” with characteristic involvement of the distal interphalangeal joints and nail malformation was observed. Synovial hyperplasia, enthesitis, cartilage and bone alterations, formation of pannus tissue, and inflammation of the skin epidermis and nail matrix appeared as early as 1 week after the treatment of mice with doxycycline and became aggravated over time. The abrogation of human TNFα expression by the removal of doxycycline 6 weeks after beginning stimulation resulted in fast resolution of the most advanced macroscopic and histologic disorders, and 3–6 weeks later, only minimal signs of disease were visible.Conclusion: Upon doxycycline administration, the doxycycline‐inducible human TNFα–transgenic mouse displays the major features of inflammatory arthritis. It represents a unique animal model for studying the molecular mechanisms of arthritis, especially the early phases of disease genesis and tissue remodeling steps upon abrogation of TNFα expression. Furthermore, unlimited crossing of doxycycline‐inducible human TNFα–transgenic mice with various knockout or transgenic mice opens new possibilities for unraveling the role of various signaling molecules acting in concert with TNFα.Keywords
Funding Information
- DFG (SFB492A17, Pa689/10-1)
This publication has 23 references indexed in Scilit:
- Animal models for arthritis: innovative tools for prevention and treatmentAnnals of the Rheumatic Diseases, 2011
- Tumor necrosis factor–interleukin‐17 interplay induces S100A8, interleukin‐1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: Rationale for combination treatment during arthritisArthritis & Rheumatism, 2011
- S100A8 and S100A9 in experimental osteoarthritisArthritis Research & Therapy, 2010
- Tumor Necrosis Factor and the consequences of its ablation in vivoMolecular Immunology, 2009
- The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancerJournal of Leukocyte Biology, 2009
- Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritisAnnals of the Rheumatic Diseases, 2008
- Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseasesJournal of Experimental Medicine, 2008
- TNF‐mediated inflammatory diseaseThe Journal of Pathology, 2007
- Ubiquitous expression of the rtTA2S-M2 inducible system in transgenic mice driven by the human hnRNPA2B1/CBX3 CpG islandBMC Developmental Biology, 2007
- An extensive phenotypic characterization of the hTNFα transgenic miceBMC Physiology, 2007